Ergocalciferol and Dronabinol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Dronabinol (dronabinol). Common drug interactions include deafness among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Dronabinol. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.

What is Dronabinol?

Dronabinol has active ingredients of dronabinol. eHealthMe is studying from 5,453 Dronabinol users. Check the latest studies of Dronabinol.



On Aug, 03, 2026

85 people who take Ergocalciferol and Dronabinol together, and have interactions are studied.

Ergocalciferol and Dronabinol drug interactions.

What are the common drug interactions of Ergocalciferol and Dronabinol, by gender? *:

female:

  1. Deafness
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  3. Fatigue (feeling of tiredness)
  4. Intestinal obstruction
  5. Neoplasm malignant (cancer tumour)
  6. Nightmare (unpleasant dream)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  8. Abdominal pain upper
  9. Accidental exposure
  10. Anaphylactic reaction (serious allergic reaction)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Pain
  3. Renal impairment (severely reduced kidney function)
  4. Depression
  5. Nausea (feeling of having an urge to vomit)
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Bone density decreased
  8. Chills (felling of cold)
  9. Fatigue (feeling of tiredness)
  10. Haemoglobin decreased

What are the common drug interactions of Ergocalciferol and Dronabinol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Anticonvulsant drug level decreased
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

10-19:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  2. Hypokalaemia (low potassium)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Confusional state
  5. Depression
  6. Gaze palsy (disorders affecting the ability to move both eyes in the same direction)
  7. Hallucination (an experience involving the perception of something not present)
  8. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  9. Mood swings (an extreme or rapid change in mood)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

20-29:

  1. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  2. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  3. Infection
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Pneumonia
  6. Renal failure (kidney dysfunction)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Depression
  10. Emotional distress

30-39:

  1. Blood immunoglobulin e increased
  2. Chest discomfort
  3. Headache (pain in head)
  4. Lip swelling
  5. Nausea (feeling of having an urge to vomit)
  6. Peripheral swelling
  7. Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Bone density decreased
  5. Emotional distress
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  7. Osteoporosis (bones weak and more likely to break)
  8. Pain
  9. Abdominal pain
  10. Bone loss

50-59:

  1. Abdominal pain
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Bone density decreased
  6. Chronic kidney disease
  7. Emotional distress
  8. Osteoporosis (bones weak and more likely to break)
  9. Pain
  10. Fatigue (feeling of tiredness)

60+:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  4. Metastases to central nervous system (cancer spreads to central nervous system)
  5. Multiple fractures
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Neuropathy peripheral (surface nerve damage)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Osteoporosis (bones weak and more likely to break)
  10. Pain

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 19 people, 22.35%
  2. Constipation: 18 people, 21.18%
  3. Pain: 17 people, 20.00%
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints): 15 people, 17.65%
  5. Hiv Infection: 12 people, 14.12%
  6. Stress And Anxiety: 11 people, 12.94%
  7. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 10.59%
  8. Diarrhea: 9 people, 10.59%
  9. High Blood Pressure: 8 people, 9.41%
  10. Depression: 8 people, 9.41%

* Approximation only. Some reports may have incomplete information.

Do you take Ergocalciferol and Dronabinol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ergocalciferol and Dronabinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ergocalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dronabinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ergocalciferol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dronabinol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ergocalciferol and dronabinol (the active ingredients of Ergocalciferol and Dronabinol, respectively), and Ergocalciferol and Dronabinol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: